MedPath

A randomized controlled trial study on the effectiveness of 17 alpha hydroxyprogesterone and micronised progesterone in preventing preterm labor of pregnant women with arrested premature labor.

Phase 3
Recruiting
Conditions
pregnant women with arrested premature labor gestational age 24-33+6 week
pregnant women with arrested premature labor, 17 alpha hydroxyprogesterone, micronised progesterone
Registration Number
TCTR20210407003
Lead Sponsor
Faculty of medicine Mahasarakham university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
48
Inclusion Criteria

1.Pregnant women with arrested premature labor gestational age 24-33+6 week, > 18 years old,
2. Have been examined ultrasound to confirm gestational age and confirm no anormaly.,
3. Cervical dilatation < 4 cms.

Exclusion Criteria

1. Pregnant woman who had contraindication to inhibit preterm labor, such as chorioamnionitis
2. Membrane leak or rupture
3. Allergy to any component of progesterone
4. Mothers with severe obstetrical or medical complications sush as severe preeclampsia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
preterm delivery at delivery time Patient reported outcome using a questionaire
Secondary Outcome Measures
NameTimeMethod
duration to prolong pregnancy period at delivery time Patient reported outcome using a questionnaire interview
© Copyright 2025. All Rights Reserved by MedPath